The goal of this proposal is to investigate the molecular mechanisms controlling angiogenesis, which is critical for sustaining tumor growth. BMK1/ERK5 is a newer member of mammalian MAP kinase family and is activated by angiogenic growth factors. Recently, data generated from our conditional knockout mice of BMK1 revealed that BMK1 is critical for angiogenesis not only during the embryonic stage but also in adulthood, most likely through its role in endothelial cells (EC). To investigate and to define the function and molecular actions of BMK1 pathway in EC and in angiogenesis, we propose (1) to investigate the signaling pathway(s) that interacts with or is regulated by the BMK1 cascade in endothelial cells and (2) to explore the mechanism of action of the BMK1 cascade during angiogenesis. These proposed studies should provide new information on the regulatory mechanisms of neovascularization by which we hope to identify novel and important targets for a more effective and specific therapeutic intervention for human cancer through inhibiting tumor-associated angiogenesis. ? ? ?

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Ault, Grace S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Deng, Xianming; Elkins, Jonathan M; Zhang, Jinwei et al. (2013) Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones. Eur J Med Chem 70:758-67
Yang, Q; Liao, L; Deng, X et al. (2013) BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction. Oncogene 32:3156-64
Chen, Runqiang; Yang, Qingkai; Lee, Jiing-Dwan (2012) BMK1 kinase suppresses epithelial-mesenchymal transition through the Akt/GSK3? signaling pathway. Cancer Res 72:1579-87
Deng, Xianming; Dzamko, Nicolas; Prescott, Alan et al. (2011) Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2. Nat Chem Biol 7:203-5
Yang, Qingkai; Lee, Jiing-Dwan (2011) Targeting the BMK1 MAP kinase pathway in cancer therapy. Clin Cancer Res 17:3527-32
Yang, Qingkai; Deng, Xianming; Lu, Bingwen et al. (2010) Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell 18:258-67
Chen, Run-Qiang; Yang, Qing-Kai; Lu, Bing-Wen et al. (2009) CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res 69:2663-8
Chen, Yanling; Lu, Bingwen; Yang, Qingkai et al. (2009) Combined integrin phosphoproteomic analyses and small interfering RNA--based functional screening identify key regulators for cancer cell adhesion and migration. Cancer Res 69:3713-20
Chen, Run-Qiang; Yang, Qing-Kai; Chen, Yan-Ling et al. (2009) Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1alpha in hypoxia. J Biol Chem 284:16752-8
Zhu, J-H; Chen, R; Yi, W et al. (2008) Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. Oncogene 27:2525-31

Showing the most recent 10 out of 17 publications